Pfizer Inc. (PFE)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:03PM EDT
After hours:
| Previous close | 43.76 |
| Open | 44.07 |
| Bid | 0.00 x 3200 |
| Ask | 0.00 x 1800 |
| Day's range | 43.49 - 44.28 |
| 52-week range | 40.94 - 61.71 |
| Volume | |
| Avg. volume | 17,741,650 |
| Market cap | 247.752B |
| Beta (5Y monthly) | 0.65 |
| PE ratio (TTM) | 8.59 |
| EPS (TTM) | 5.14 |
| Earnings date | 01 Nov 2022 |
| Forward dividend & yield | 1.60 (3.66%) |
| Ex-dividend date | 03 Nov 2022 |
| 1y target est | 56.81 |
- Zacks
Should Investors Buy Bristol Myers Squibb Stock?
BMY's YTD performance indicates the stock has been a viable hedge against inflation because people can ill afford to cut back on health-focused spending.
- Zacks
Pfizer (PFE) Gains But Lags Market: What You Should Know
Pfizer (PFE) closed the most recent trading day at $44.14, moving +0.87% from the previous trading session.
- Business Wire
Pfizer Completes Acquisition of Biohaven Pharmaceuticals
NEW YORK, October 03, 2022--Pfizer Inc. (NYSE: PFE) announced today the completion of its acquisition of Biohaven Pharmaceutical Holding Company Ltd., the maker of NURTEC® ODT (rimegepant), an innovative migraine therapy approved for both acute treatment and prevention of episodic migraine in adults.
© 2022 Yahoo. All rights reserved.
